Review
. 2018 Jul;61(1):T69-T86.
doi: 10.1530/JME-17-0311. Epub 2018 Mar 13.
Affiliations
PMID: 29535161 DOI: 10.1530/JME-17-0311
Review
IGF1 receptor signaling pathways
Fumihiko Hakuno et al. J Mol Endocrinol. 2018 Jul.
Abstract
Insulin-like growth factors (IGFs) bind specifically to the IGF1 receptor on the cell surface of targeted tissues. Ligand binding to the α subunit of the receptor leads to a conformational change in the β subunit, resulting in the activation of receptor tyrosine kinase activity. Activated receptor phosphorylates several substrates, including insulin receptor substrates (IRSs) and Src homology collagen (SHC). Phosphotyrosine residues in these substrates are recognized by certain Src homology 2 (SH2) domain-containing signaling molecules. These include, for example, an 85 kDa regulatory subunit (p85) of phosphatidylinositol 3-kinase (PI 3-kinase), growth factor receptor-bound 2 (GRB2) and SH2-containing protein tyrosine phosphatase 2 (SHP2/Syp). These bindings lead to the activation of downstream signaling pathways, PI 3-kinase pathway and Ras-mitogen-activated protein kinase (MAP kinase) pathway. Activation of these signaling pathways is known to be required for the induction of various bioactivities of IGFs, including cell proliferation, cell differentiation and cell survival. In this review, the well-established IGF1 receptor signaling pathways required for the induction of various bioactivities of IGFs are introduced. In addition, we will discuss how IGF signals are modulated by the other extracellular stimuli or by themselves based on our studies.
Keywords: MAP kinase; PI 3-kinase; insulin receptor substrate (IRS); insulin-like growth factor (IGF); insulin-like growth factor (IGF)-I receptor; signal transduction.
© 2018 Society for Endocrinology.
PubMed Disclaimer